期刊文献+

阿地福韦体外抗乙肝病毒的活性 被引量:5

Anti-hepatitis B virus effect of 9-(2-phosphnylmethoxyethyl) adenine (PMEA) in vitro
下载PDF
导出
摘要 目的 :阿地福韦 (adefoirdipivoxil,Bis POMPMEA)是一新的广谱、抗病毒核苷类药物。本实验评价阿地福韦体外抗乙肝病毒 (HBV)的活性。方法 :应用HBVDNA转染的人肝癌细胞株 (HepG2 2 .2 .15 ) ,阿地福韦体外抗乙肝病毒 (HBV)的活性评价。结果 :阿地福韦能显著减少HepG2 2 .2 .15细胞培养上清液中HBsAg ,HBVDNA的分泌 ;Southern印迹法表明 :阿地福韦能明显地抑制HBV复制中间体及共价环状闭合DNA。该实验药物浓度对细胞形态、计数及总细胞DNA无明显影响。阿地福韦具有较强的体外抗HBV活性 ,同时细胞毒性作用不明显。结论 :阿地福韦作为新的抗HBV药物 。 OBJECTIVE To study the inhibitory effect of 9 (2 phosphnylmethoxyethyl) adenine (PMEA) on hepatitis B virus (HBV) replication in vitro.METHODS To evaluate inhibitory effect of PMEA with HBV transfected Hep G 2 2.2.15 cell line in vitro.RESULTS PMEA with remarkable reduce the secret of HBsAg and HBV DNA in Hep G 2 2.2.15 cell culture medium.Southern blot analysis demonstrated that PMEA could remarkable inhibit HBV replicative intermediates including covalently closed circular DNA.PMEA didn't significantly affect on cell morphology,cell counting and total cellular DNA on this study.These results indicate that PMEA can inhibit HBV replication in vitro;meanwhile,the toxic effect to cells is not significant.CONCLUSIONS PMEA,as a novel,broad spectrum nucleotide analogue has anti HBV activity,can be used further in clinical study.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2001年第11期656-658,共3页 Chinese Journal of Hospital Pharmacy
关键词 阿地福韦 乙肝病毒 HEP G22.2.15 乙型肝炎 抗病毒核苷类药物 adefoir dipivoxil hepatitis B virus Hep G 2 2.2.15 cell
  • 相关文献

参考文献3

  • 1Xiong X,Hepatology,1997年,26卷,4期,1211页
  • 2Balzarini J,Proc Nat Acad Sci USA,1991年,88卷,1499页
  • 3Sells M A,Proc Nat Acad Sci USA,1987年,84卷,1005页

同被引文献73

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:467
  • 2黄德福,林琴.阿德福韦抗乙型肝炎病毒研究进展[J].中西医结合肝病杂志,2001,11(S1):139-141. 被引量:1
  • 3江军,蔡雄,缪晓辉.阿德福韦酯对慢性乙型肝炎患者外周血干扰素和白细胞介素的影响[J].肝脏,2006,11(2):86-88. 被引量:12
  • 4XIONG X,FLORES C,YANG H,et al.Mutations in hepatitisB DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovirin vitro.Hepatology,1998,28(6):1669-1673.
  • 5NICHOLL AJ,COLLEDGE DL,TOOLE JJ,et al.Inhibition of duck hepatitis B vires replication by 9-(2-phosphonyl-methoxyethyl)adenine,ana cyclic phosphonate nucleoside analogue.Amimicrob Agents Chemother,1998,42(12):3130-3135.
  • 6Chisari FV. Hepatitis B virus transgenic mice: insights into the vires and the disease[J]. Hepatology, 1995, 22(4 Pt 1):1316-1325.
  • 7于乐成,顾长海.Th1型和Th2型细胞因子与肝损伤[M]//顾长海,王宇明.肝功能衰竭.北京:人民卫生出版社,2002:84-86.
  • 8Barnaba V, Franco A, Paroli M, etal. Selective expansion of cytotoxic T lymphocytes with a CD4^+CD56^+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus [J]. J Immunol, 1994, 152 (6):3074-3087.
  • 9Lee M, Lee M, Lee SK, et al. Expression of Th1 and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients[J]. J Korean Med Sci, 1999, 14(2):175-181.
  • 10Penna A, Del Prete G, Cavalli A, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B[J]. Hepatology, 1997, 25(4):.1022-1027.

引证文献5

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部